TT Electronics, a global provider of engineered electronics for performance critical applications, today announced that the U.S. Federal Drug Administration (FDA) has confirmed registration for its Cleveland, Ohio manufacturing facility. The registration allows the company to manufacture finished medical instruments and devices, like imaging and diagnostic systems, in the USA.
As an FDA registered establishment, the facility is now recognised under the stringent standards of the FDA, reinforcing the company’s commitment to providing the most comprehensive range of services to its global customers.
TT Electronics plc (LON:TTG) is a provider of engineered electronics applications for performance-critical applications. The Company works with customers in the industrial, medical, aerospace and defence, and transportation sectors.